SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-177276
Filing Date
2015-05-07
Accepted
2015-05-07 16:47:55
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d905727d10q.htm 10-Q 290045
2 EX-31.1 d905727dex311.htm EX-31.1 8555
3 EX-31.2 d905727dex312.htm EX-31.2 8568
4 EX-32.1 d905727dex321.htm EX-32.1 4901
  Complete submission text file 0001193125-15-177276.txt   3260769

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT omed-20150331.xml EX-101.INS 408549
6 XBRL TAXONOMY EXTENSION SCHEMA omed-20150331.xsd EX-101.SCH 33775
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20150331_cal.xml EX-101.CAL 45553
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20150331_def.xml EX-101.DEF 126660
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20150331_lab.xml EX-101.LAB 270165
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20150331_pre.xml EX-101.PRE 215952
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 15842500
SIC: 2834 Pharmaceutical Preparations